87 related articles for article (PubMed ID: 17516921)
1. A darker side to p53.
Gaitonde S; Ronai Z
Pigment Cell Res; 2007 Jun; 20(3):148-9. PubMed ID: 17516921
[No Abstract] [Full Text] [Related]
2. The sunny side of p53.
Oren M; Bartek J
Cell; 2007 Mar; 128(5):826-8. PubMed ID: 17350568
[TBL] [Abstract][Full Text] [Related]
3. Central role of p53 in the suntan response and pathologic hyperpigmentation.
Cui R; Widlund HR; Feige E; Lin JY; Wilensky DL; Igras VE; D'Orazio J; Fung CY; Schanbacher CF; Granter SR; Fisher DE
Cell; 2007 Mar; 128(5):853-64. PubMed ID: 17350573
[TBL] [Abstract][Full Text] [Related]
4. Role of apoptosis in basal cell and squamous cell carcinoma formation.
Erb P; Ji J; Wernli M; Kump E; Glaser A; Büchner SA
Immunol Lett; 2005 Aug; 100(1):68-72. PubMed ID: 16054233
[TBL] [Abstract][Full Text] [Related]
5. The glutathione-S-transferase P1 polymorphisms correlates with changes in expression of TP53 tumor suppressor in cutaneous basal cell carcinoma.
Gorji H; Shahbazi N; Habibollahi P; Tavangar SM; Firooz A; Ghahremani MH
J Dermatol Sci; 2009 Dec; 56(3):208-10. PubMed ID: 19800766
[No Abstract] [Full Text] [Related]
6. A healthy tan?
Barsh G; Attardi LD
N Engl J Med; 2007 May; 356(21):2208-10. PubMed ID: 17522405
[No Abstract] [Full Text] [Related]
7. Mutation spectra of epidermal p53 clones adjacent to basal cell carcinoma and squamous cell carcinoma.
Bäckvall H; Strömberg S; Gustafsson A; Asplund A; Sivertsson A; Lundeberg J; Ponten F
Exp Dermatol; 2004 Oct; 13(10):643-50. PubMed ID: 15447725
[TBL] [Abstract][Full Text] [Related]
8. Analyses of the tumour suppressor ING1 expression and gene mutation in human basal cell carcinoma.
Chen B; Campos EI; Crawford R; Martinka M; Li G
Int J Oncol; 2003 Apr; 22(4):927-31. PubMed ID: 12632089
[TBL] [Abstract][Full Text] [Related]
9. POMC and TP53 genetic variability and risk of basal cell carcinoma of skin: Interaction between host and genetic factors.
Rizzato C; Scherer D; Rudnai P; Gurzau E; Koppova K; Hemminki K; Canzian F; Kumar R; Campa D
J Dermatol Sci; 2011 Jul; 63(1):47-54. PubMed ID: 21536413
[TBL] [Abstract][Full Text] [Related]
10. Carcinogen-specific mutation pattern in the p53 tumour suppressor gene in UV radiation-induced basal cell carcinoma.
Weihrauch M; Bader M; Lehnert G; Wittekind C; Tannapfel A; Wrbitzky R
Int Arch Occup Environ Health; 2002 Apr; 75(4):272-6. PubMed ID: 11981662
[TBL] [Abstract][Full Text] [Related]
11. [Expression of bcl-2, bax and p53 protein in the basal cell carcinoma].
Yan L; Chen M; Yu G
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(2):179-80. PubMed ID: 11938785
[TBL] [Abstract][Full Text] [Related]
12. Infrequent p53 mutations in arsenic-related skin lesions.
Castrén K; Ranki A; Welsh JA; Vähäkangas KH
Oncol Res; 1998; 10(9):475-82. PubMed ID: 10223623
[TBL] [Abstract][Full Text] [Related]
13. Tanning, p53 and PCMR.
Goding C
Pigment Cell Melanoma Res; 2008 Oct; 21(5):499-500. PubMed ID: 18821854
[No Abstract] [Full Text] [Related]
14. Divergence between the high rate of p53 mutations in skin carcinomas and the low prevalence of anti-p53 antibodies.
Moch C; Moysan A; Lubin R; de la Salmonière P; Soufir N; Galisson F; Vilmer C; Venutolo E; Le Pelletier F; Janin A; Basset-Séguin N
Br J Cancer; 2001 Dec; 85(12):1883-6. PubMed ID: 11747330
[TBL] [Abstract][Full Text] [Related]
15. A study of mitochondrial DNA D-loop mutations and p53 status in nonmelanoma skin cancer.
Prior SL; Griffiths AP; Lewis PD
Br J Dermatol; 2009 Nov; 161(5):1067-71. PubMed ID: 19624548
[TBL] [Abstract][Full Text] [Related]
16. Locally advanced basal cell carcinoma has a distinct methylation and transcriptomic profile.
Brinkhuizen T; van Geel M; Denil SL; De Meyer T; Kelleners-Smeets NW; Lohuis PJ; Hoebers FJ; Winnepenninckx VJ; van Steensel MA; Mosterd K
Exp Dermatol; 2016 Apr; 25(4):316-8. PubMed ID: 26662714
[No Abstract] [Full Text] [Related]
17. Roles of the transcription factor p53 in keratinocyte carcinomas.
Brash DE
Br J Dermatol; 2006 May; 154 Suppl 1():8-10. PubMed ID: 16712710
[TBL] [Abstract][Full Text] [Related]
18. Melanocortin 1 receptor variants: functional role and pigmentary associations.
Dessinioti C; Antoniou C; Katsambas A; Stratigos AJ
Photochem Photobiol; 2011; 87(5):978-87. PubMed ID: 21749400
[TBL] [Abstract][Full Text] [Related]
19. Frequent downregulation of DMBT1 and galectin-3 in epithelial skin cancer.
Mollenhauer J; Deichmann M; Helmke B; Müller H; Kollender G; Holmskov U; Ligtenberg T; Krebs I; Wiemann S; Bantel-Schaal U; Madsen J; Bikker F; Klauck SM; Otto HF; Moldenhauer G; Poustka A
Int J Cancer; 2003 Jun; 105(2):149-57. PubMed ID: 12673672
[TBL] [Abstract][Full Text] [Related]
20. Mutational spectrum of p53 gene in arsenic-related skin cancers from the blackfoot disease endemic area of Taiwan.
Hsu CH; Yang SA; Wang JY; Yu HS; Lin SR
Br J Cancer; 1999 Jun; 80(7):1080-6. PubMed ID: 10362120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
